Germany In-vitro Diagnostics Market

The Germany in-vitro diagnostics market size is projected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing private hospitals, independent testing laboratories, and the growing demand for instant testing and personalized medicine.

In vitro diagnostics are medical equipment, tests, and reagents that are used to diagnose health conditions. In addition, these instruments are also used to analyze tissue and body fluid samples collected from patients. In addition, there are different types of in vitro diagnosis using different methods, such as immunodiagnostic, tissue diagnosis, hematology, and molecular diagnosis.

In addition, in-vitro diagnosis is used to diagnose various diseases, such as infectious diseases, cancer, heart, and kidney diseases. The use and management of in vitro diagnostics require technical knowledge, which is why instruments are used for diagnosis in specialized medical institutions.

IVD is medical equipment and accessories used to test samples such as blood, urine, and tissue samples to detect infection, prevent disease, monitor drug treatment, and diagnose health conditions. The introduction of new methods for rapid diagnosis of
disease is expected to increase the demand for in vitro diagnostic.

The Covid-19 pandemic affected the demand and supply of Germany in-vitro diagnostics market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.

Market Trends, Drivers, Restraints, and Opportunities

• Rising geriatric population and growing cases of infectious and chronic diseases is expected to boost the market during the forecast period.
• Increasing prevalence of automatic in-vitro diagnostic devices by hospitals and clinics is anticipated to drive the market during the forecast period.
• High volatility in cost of in-vitro devices and strict regulations by government for approval of these devices is projected to restrict the market growth.
• Lack of skilled labor to operate in-vitro devices with lack of standardization and unfavorable reimbursement policy in the country present as major challenges that can hamper the market during the forecast period.
• R&D investment and development of biomarkers and development of self-test devices is projected to offer significant opportunities for the market players.

Scope of In-vitro Diagnostics Market Report

The report on the Germany in-vitro diagnostic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

In-vitro Diagnostics Market Segment Insights

The molecular diagnostics segment is projected to represent a major market share

Based on test types, the in-vitro diagnostics market is divided into clinical chemistry, molecular diagnostics, immuno diagnostics, hematology, and others. The molecular diagnostics segment is expected to represent a key share of the market during the forecast period. Molecular diagnostics are used to analyze biomarkers of pathogens or changes in the genome and proteome.

According to the technology used, molecular diagnostic equipment can be divided into chips and microarrays, mass spectrometry, next-generation sequencing methods, polymerase chain reaction methods, cytogenetic, and molecular imaging.

The major participants have adopted strategic measures such as new product development, cooperation, acquisitions, and R&D financing to consolidate their position in the German market. The aforementioned factors are expected to drive the segment during the forecast period.

The reagents segment is expected to grow at a significant pace

On the basis of products, the in-vitro diagnostics market is segregated into reagents, instruments, and others. The reagents segment is expected to hold a key share of the market during the forecast period. Increase in research and development of chronic disease diagnosis is one of the main driving forces for the development of reagent. Increasing number of IVD tests is one of the most important growth drivers in the field of reagents.

On the other hand, the instrument segment is anticipated to expand at a rapid pace during the forecast period owing to the introduction of technologically advanced tools and rapid testing tools and rising aging population. In vitro diagnostics are expected to play an important role in diagnostics, such as blood glucose meters, chemical analyzers, clinical chemistry analyzers, blood analyzers, urine analyzers, and immunochemical analyzers.

The reusable in-vitro devices segment is anticipated to expand at rapid CAGR

In terms of usability, the in-vitro diagnostics market is bifurcated into disposable in-vitro devices and reusable in-vitro devices. The reusable in-vitro devices segment is expected to hold a key share of the market during the forecast period. Some reusable devices include forceps, stethoscopes, and endoscopes.

Growth of the market is attributed to increasing demand of in-vitro toxicology testing in pharmaceuticals sector and increasing advancement in genetics. The disposable IVD devices segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rising prevalence of diabetes disease and rapid technological advancement in in-vitro toxicology testing methods.

The oncology segment is expected to grow at a rapid pace

In terms of applications, the in-vitro diagnostics market is divided into autoimmune diseases, infectious devices, cardiology, nephrology, oncology, and others. The oncology segment is expected to represent a key share of the market during the forecast period. Growth of the market is attributed to high cost of several diagnostic platforms and rise in demand for IVD kits.

The infectious disease segment is anticipated to expand at a rapid pace during the forecast period due to factors such as increasing development & research procedures and changing lifestyles. On the other hand, the cardiology segment is anticipated to expand at a rapid pace during the forecast period. Cardiovascular diseases such as coronary artery disease, arrhythmia and stroke are becoming more and more prevalent worldwide, and the demand for in vitro diagnostic equipment is anticipated to increase.

The hospitals segment is estimated to expand at a high CAGR

Based on end-users, the in-vitro diagnostics market is divided into hospitals, clinical laboratories, clinics, and others. The hospitals segment is expected to represent a key share of the market during the forecast period owing to increasing number of hospitals creating strong demand for in-vitro diagnostic testing.

The demand for fast and accurate results from the biosensor, pregnancy kit and blood glucose meter is one of the main reasons for the rapid growth of the medical practice sector. Increasing use of equipment in hospitals and medical practices, especially in remote and rural areas, has stimulated demand for point-of-care testing, followed by an increase in doctors and hospital offices.

Segments

The Germany in-vitro diagnostics market has been segmented on the basis of

Test Types

• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Others

Products

• Reagents
• Instruments
• Others

Applications

• Infectious Devices
• Oncology
• Cardiology
• Autoimmune Diseases
• Nephrology
• Others

Usability

• Reusable In-vitro Devices
• Disposable In-vitro Devices

End Users

• Hospitals
• Clinical Laboratories
• Clinics
• Others

Key Players

• F. Hoffmann La Roche Ltd.
• Epigenomics Inc.
• Qiagen N.V
• Abbott Laboratories
• Siemens Healthcare GmbH

Competitive Landscape

Key players competing in the in-vitro diagnostic market include F. Hoffmann La Roche Ltd.; Epigenomics Inc.; Qiagen N.V; Abbott Laboratories; and Siemens Healthcare GmbH

Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.